Summary
Unspecific cellular immune reactivity in 30 patients with squamous cell carcinoma of the head and neck was compared with those in 30 healthy controls. Assays were performed in vitro to evaluate the blastogenic response of lymphocytes to the mitogens PHA (phytohemagglutinin), Con A (Concanavalin A) and PWM (pokeweed mitogen) and to quantify T-rosette-forming lymphocytes. The in vivo assay used was the delayed cutaneous hypersensitivity reaction to DNCB (dinitro-chlor-benzene). Tests were performed in all patients every 4 weeks either for a total of 1 year or until death. Tumor patients were followed up for 5 years. Compared to healthy controls tumor patients demonstrated significant impairment of unspecific immune reactivity. Surgery, chemotherapy, and radiotherapy led temporarily to a further decrease of immune reactivity. There was no correlation between unspecific immune reactivity and tumor stage, course of the disease, and prognosis. It was not possible to give any useful statement for patients with squamous cell carcinoma of the head and neck by determining their unspecific immune reactivity.
Zusammenfassung
Bei 30 Patienten mit Plattenepithel-Karzinomen im Kopf-Hals-Bereich und 30 gesunden Kontrollpersonen wurden unspezifische Immunparameter bestimmt (Lymphozytenstimulation mit PHA, ConA, PWM; relativer und absoluter T-Zell-Anteil; Hautreaktivität auf DNCB). Die Untersuchungen wurden bei jedem Patienten in vierwöchigem Intervall für mindestens ein Jahr durchgeführt. Die Tumorpatienten wurden klinisch über fünf Jahre regelmäßig nachuntersucht. Für Patienten mit Kopf-Hals-Karzinomen ließ sich gegenüber gesunden Kontrollpersonen eine verminderte unspezifische Immunreaktivität nachweisen.
Jede Behandlungsart (Chirurgie, Chemotherapie, Strahlentherapie) führte zu einer weiteren, vorübergehenden Abnahme der geprüften Parameter. Eine Abhängigkeit zwischen unspezifischen Immunparametern und Tumorstadium, klinischem Verlauf der Erkrankung und Prognose konnte nicht nachgewiesen werden. Ein Vergleich der unspezifischen Immunreaktivität zwischen Patienten mit Kopf-Hals-Karzinomen und Alkoholikern zeigte keine Unterschiede. Es war nicht möglich auf Grund der durchgeführten Untersuchungen eine klinisch relevante Aussage zu machen. Es wird in Frage gestellt, ob die untersuchten Parameter überhaupt in einen Zusammenhang mit der Tumorerkrankung stehen.
Similar content being viewed by others
Abbreviations
- UICC:
-
Union Internationale Contre le Cancer
- PHA:
-
Phytohämagglutinin
- ConA:
-
Concanavalin A
- PWM:
-
Pokeweed mitogen
- DNCB:
-
Dinitrochlorbenzol
- cpm:
-
counts per minute
Literatur
Al-Sarraf M, Sardesai S, Valtkevicus VK (1972) Clinical immunologic responsiveness in malignant disease. Oncology 26: 357
Anthony HM, Kirk JA, Madsen KE, Mason MK, Templeman GH (1975) E and Eac rosetting lymphocytes in patients with carcinoma of bronchus. II. A sequential study of thirty patients: Effect of BCG. Clin Exp Immunol 20:41
Bier J, Bitter K, Nicklisch U (1977) Immundefekte bei Patienten mit Plattenepithelkarzinomen der Mundhöhle. Dtsch Z Mund-Kiefer-Gesichts-Chir 1:210
Bier J, Bitter K, Nicklisch U (1978) Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of the head and neck. J Maxillofac Surg 6:75
Bone G, Camplejohn R (1973) The role of cellular immunity in control of neoplasia. Br J Surg 60:824
Burnet TM (1970) The concept of immunological surveillance. Prog Exp Tumor Res 13: 1
Campbell AC, Hersey P, MacLennan ICM, Kay HEM, Pike MC and the Medical Research Council's Working Party on Leukemia in Childhood (1973a) Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukemia. Br Med J 2:385
Campbell AC, Hersey P, Harding P, Hollingsworth PM, Skinner J, MacLennan ICM (1973b) Effects of anti-cancer agents on immunological status. Br J Cancer 28:254
Catalona WJ, Chretien PB (1973) Abnormalities of quantitative dinitrochlorbenzene sensitization in cancer patients: Correlation with tumor stage and histology. Cancer 31:353
Catalona WJ, Sample WF, Chretien PB (1973) Lymphocyte reactivity in cancer patients: Correlation with tumor histology and clinical stage. Cancer 31:65
Chakravorty RC, Curutchet HP, Coppolla FS, Choon MP, Blaycock WK, Lawrence W (1973) The delayed hypersensitivity reaction in the cancer patient. Observation on sensitization by DNCB. Surgery 73:730
Chretien PB, Crowder WL, Gartner HR, Sample WF, Catalona WJ (1973) Correlation of preoperative lymphocyte reactivity with clinical course of cancer patients. Surg Gynecol Obstet 136:380
Chretien PB, Ketcham AS (1973) Quantitation of immunologic defects in cancer patients. Seventh National Cancer Conference Proceedings. Am Cancer Soc Inc 14:123
Claudy AL, Viac J, Pelletier N (1975) Prognostic correlations in malignant melanoma. Eur J Cancer 11:821
Dellon AL, Potvin C, Chretien PB (1975) Thymus-dependent lymphocyte levels in bronchogenetic carcinoma correlation with histology, clinical stage, and clinical course after surgical treatment. Cancer 35:687
Eilber FR, Nizze JA, Morton DL (1975) Sequential evaluation of general immune competence in cancer patients: Correlation with clinical course. Cancer 35:660
Fraumeni J (1969) Constitutional disorders of man predisposing to leukemia and lymphoma. Natl Cancer Inst Monogr 32:221
Hakulinen T, Lehtimäk L, Lehtonen M, Teppo L (1974) Cancer morbidity among two male cohorts with increased alcohol consumption in Finland. J Natl Cancer Inst 52:1711
Han T, Sokal JE (1970) Lymphocyte response to phytohemagglutinin in Hodgkin's disease. Am J Med 48:728
Hellström I, Warner GA, Hellström KE (1973) Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma. Int J Cancer 11:280
Hersh EM, Oppenheimer JJ (1965) Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med 4:1006
Hersh EM, Guttermann JU, Mavligit GM, Mountain CW, McBride CM, Burgess MA (1976) Immunocompetence, immunodeficiency, and prognosis in cancer. Ann NY Acad Sci 276:386
Hoge AF, Hartsuck JM, Kollmorgen GM (1973) Endocrine and immunologic studies in breast cancer. Am J Surg 126:722
Kenady DE, Chretien PB, Potvin C (1977) Effect of thymosin in vitro on T-cell levels during radiation therapy. Correlations with radiation portal and initial T-cell levels. Cancer 39:642
Lundy J, Raaf JH, Deakins S, Wanebo HJ (1975) The acute and chronic effects of alcohol on the human immunic system. Surg Gynecol Obstet 141:212
Millard RE (1965) Effect of previous irradiation on the transformation of blood lymphocytes. J Clin Pathol 18:783
Morton DL, Eilber FR, Malmgren RA, Wood WC (1970) Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery 68:159
Ohno R, Hersh EM (1970) The inhibition of lymphocyte blastogenesis by L-asparaginase. Blood 35:250
Prehn RT (1976) Do tumors grow because of the immune response of the host? Transplant Rev 28:34
Ramot B, Binaminov M, Shoham CH, Rosenthal R (1976) Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease. N Engl J Med 294:809
Riddle PR, Berenbaum MC (1967) Postoperative depression on the lymphocyte response to phytohemagglutinin. Lancet I:746
Rygaard J, Povlsen C (1976) The nude mouse vs. the hypothesis of immunological surveillance. Transplant Rev 28:43
Wanebo HJ, Jun MY, Strong EW, Oettgen H (1975) T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg 130:445
Westburg SP, Stone OJ (1973) Multiple cutaneous squamous cell carcinomas during immunosuppressive therapy. Arch Dermatol 107:393
Whiteside MG, Cauchi MN, Paton CH, Stone J (1976) Chemoimmunotherapy for maintenance in acute myeloblastic leukemia. Cancer 38:1581
Wybran J, Fudenberg HH (1973) Thymus-derived rosette-forming cells in various human disease states: Cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest 52:1026
Wybran J, Spitler LE, Fudenberg HH (1973) Rosette-forming cells and melanoma. Clin Res 21:655
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bier, J., Nicklisch, U. Verlaufsuntersuchungen unspezifischer Immunparameter bei Patienten mit Kopf-Hals-Karzinomen. Arch Otorhinolaryngol 232, 145–163 (1981). https://doi.org/10.1007/BF00505034
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00505034